1Aguayo A,Estey E,Kantarjian H.Cellular vascular growth factor is a predictor of outcome in patients with acute myeloid leukemia[J].Blood,1999,94(11):3717.
2Bellamy WT,Richter L,Frutiger Y,et al.Expression of vascular endothelial growth factor and its receptors in hematopoietic malignances[J].Cancer Res,1999,59(2):728.
3Dias S,Choy M,Alitalo K,et al.VEGF(165) promotes survival of leukemic cells by Hsp90 mediated induction of Bcl-2 expression and apoptosis inhibition[J].Blood,2002,99(6):2179.
4Koistinen P,Siitonen T,Mantymaa P,et al.Regulation of the acute myeloid leukemia cell line OCI/AML-2 by endothelial nitric oxide synthase under the control of a vascular endothelial growth factor signaling system[J].Leukemia,2001,15(9):1433.
6Fabbro D,Ruetz S,Bodis S,rt al.PKC412-a protein kinase inhibitor with a broad therapeutic potential[J].Antieaneer Drug Des,2000,15(1):17.
7Ruan GR,Liu YR,Chen SS,et al.Effect of antisense VEGF cDNA transfection on the growth of chronic myeloid leukemia K562 cells in vitro and in nude mice[J].Leuk Res,2004,28(7):763.
8Zhang L, Yang N, Mohamed-Hadley A, et al. Vector-based RNAi,a novel tool for isoform-specific knock-down of VEGF and anti-angiogenesis gene therapy of cancer[J].Biochem Biophys Res Commun,2003,303(4):1169.
9Karp JE, Gojo I, Pili R, et al.Targeting vascular endothelial growth factor for relapsed and refractory adult acute myelogenous leukemias:therapy with sequential 1-beta-d-arabinofuranosylcytosine,mitoxantrone,and bevacizumab[J].Clin Cancer Res,2004,10(11):3577.
10Vitaliti A,Wittmer M,Steiner R,et al.Inhibition of tumor angiogenesis by a single-chain antibody directed against vascular endothelial growth factor[J].Cancer Res,2000,60(16):1311.
2DIAS S,HATTORI K,ZHU Z,et al.Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration[J].J Clin Invest,2000,106(4):511 -521.
3DE BONT E S, ROSATI S,JACOBS, et al. Increased bone marrow vascularization in patients with acute myeloid leukaemia: a possible role for vascular endothelial cell growth factor [J]. Br J Haematol, 2001, 113 :296--304.
4TOI M, MATSUMOTO T, BANDO H. Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications[J]. Lancet Oncol, 2001,2 : 667 --673.
5BELLAMY W T,RICHTER L,FRUTIGER Y,et al. Expression of vascular endothelial growth factor and its receptors in hematopoietic malign-ances [J]. Cancer Res, 1999,59 : 728-- 733.
6DIAS S. HATTON K. ZHU Z. et al. Autocrine stimulation of VEGFR-2 activations human leukemia cell growth and migration [J]. J Clin In-vest, 2000, 106: 511-521.
